Royal Bank Of Canada Immuneering Corp Transaction History
Royal Bank Of Canada
- $471 Billion
- Q3 2024
A detailed history of Royal Bank Of Canada transactions in Immuneering Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 11,294 shares of IMRX stock, worth $23,491. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,294Holding current value
$23,491% of portfolio
0.0%Shares
12 transactions
Others Institutions Holding IMRX
# of Institutions
42Shares Held
4.66MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.07MShares$2.23 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD810KShares$1.69 Million0.0% of portfolio
-
Black Rock Inc. New York, NY533KShares$1.11 Million0.0% of portfolio
-
Morgan Stanley New York, NY449KShares$934,5660.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny246KShares$512,2410.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $54.9M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...